These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15626775)

  • 1. Gene transfer mediated by native versus fibroblast growth factor-retargeted adenoviral vectors into lung cancer cells.
    Qin M; Escuadro B; Sharma S; Batra RK
    Am J Respir Cell Mol Biol; 2005 Mar; 32(3):211-7. PubMed ID: 15626775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retargeting of adenoviral vector using basic fibroblast growth factor ligand for malignant glioma gene therapy.
    Wang W; Zhu NL; Chua J; Swenson S; Costa FK; Schmitmeier S; Sosnowski BA; Shichinohe T; Kasahara N; Chen TC
    J Neurosurg; 2005 Dec; 103(6):1058-66. PubMed ID: 16381193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coxsackievirus adenovirus receptor expression predicts the efficiency of adenoviral gene transfer into non-small cell lung cancer xenografts.
    Qin M; Chen S; Yu T; Escuadro B; Sharma S; Batra RK
    Clin Cancer Res; 2003 Oct; 9(13):4992-9. PubMed ID: 14581374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cells.
    Gupta V; Wang W; Sosnowski BA; Hofman FM; Chen TC
    Neurosurg Focus; 2006 Apr; 20(4):E26. PubMed ID: 16709032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in mice.
    Gu DL; Gonzalez AM; Printz MA; Doukas J; Ying W; D'Andrea M; Hoganson DK; Curiel DT; Douglas JT; Sosnowski BA; Baird A; Aukerman SL; Pierce GF
    Cancer Res; 1999 Jun; 59(11):2608-14. PubMed ID: 10363982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models.
    Van Houdt WJ; Wu H; Glasgow JN; Lamfers ML; Dirven CM; Gillespie GY; Curiel DT; Haviv YS
    Neuro Oncol; 2007 Jul; 9(3):280-90. PubMed ID: 17522331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor.
    Kaner RJ; Worgall S; Leopold PL; Stolze E; Milano E; Hidaka C; Ramalingam R; Hackett NR; Singh R; Bergelson J; Finberg R; Falck-Pedersen E; Crystal RG
    Am J Respir Cell Mol Biol; 1999 Mar; 20(3):361-70. PubMed ID: 10030833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor 2-retargeted adenoviral vectors exhibit a modified biolocalization pattern and display reduced toxicity relative to native adenoviral vectors.
    Printz MA; Gonzalez AM; Cunningham M; Gu DL; Ong M; Pierce GF; Aukerman SL
    Hum Gene Ther; 2000 Jan; 11(1):191-204. PubMed ID: 10646650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of adenoviral vectors via fibroblast growth factor receptors involves intracellular pathways that differ from the targeting ligand.
    Hoganson DK; Sosnowski BA; Pierce GF; Doukas J
    Mol Ther; 2001 Jan; 3(1):105-12. PubMed ID: 11162317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by alpha(v)beta1 integrin and can be modulated by changes in beta1 integrin function.
    Davison E; Kirby I; Whitehouse J; Hart I; Marshall JF; Santis G
    J Gene Med; 2001; 3(6):550-9. PubMed ID: 11778901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retargeted delivery of adenoviral vectors through fibroblast growth factor receptors involves unique cellular pathways.
    Doukas J; Hoganson DK; Ong M; Ying W; Lacey DL; Baird A; Pierce GF; Sosnowski BA
    FASEB J; 1999 Aug; 13(11):1459-66. PubMed ID: 10428769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting adenoviral vectors using heterofunctional polyethylene glycol FGF2 conjugates.
    Lanciotti J; Song A; Doukas J; Sosnowski B; Pierce G; Gregory R; Wadsworth S; O'Riordan C
    Mol Ther; 2003 Jul; 8(1):99-107. PubMed ID: 12842433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors.
    Nakamura T; Sato K; Hamada H
    Hum Gene Ther; 2002 Mar; 13(5):613-26. PubMed ID: 11916485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New generation adenoviral vectors improve gene transfer by coxsackie and adenoviral receptor-independent cell entry.
    Reynolds PN; Curiel DT
    Kidney Int; 2002 Jan; 61(1 Suppl):S24-31. PubMed ID: 11841608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphavbeta3.
    Brüning A; Köhler T; Quist S; Wang-Gohrke S; Moebus VJ; Kreienberg R; Runnebaum IB
    Hum Gene Ther; 2001 Mar; 12(4):391-9. PubMed ID: 11242531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus vectors with chimeric type 5 and 35 fiber proteins exhibit enhanced transfection of human pancreatic cancer cells.
    Toyoda E; Doi R; Kami K; Mori T; Ito D; Koizumi M; Kida A; Nagai K; Ito T; Masui T; Wada M; Tagawa M; Uemoto S
    Int J Oncol; 2008 Dec; 33(6):1141-7. PubMed ID: 19020746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells.
    Cripe TP; Dunphy EJ; Holub AD; Saini A; Vasi NH; Mahller YY; Collins MH; Snyder JD; Krasnykh V; Curiel DT; Wickham TJ; DeGregori J; Bergelson JM; Currier MA
    Cancer Res; 2001 Apr; 61(7):2953-60. PubMed ID: 11306473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors limiting adenovirus-mediated gene transfer into human lung and pancreatic cancer cell lines.
    Pearson AS; Koch PE; Atkinson N; Xiong M; Finberg RW; Roth JA; Fang B
    Clin Cancer Res; 1999 Dec; 5(12):4208-13. PubMed ID: 10632362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased adenoviral transduction efficacy in human laryngeal carcinoma cells resistant to cisplatin is associated with increased expression of integrin alphavbeta3 and coxsackie adenovirus receptor.
    Ambriović-Ristov A; Gabrilovac J; Cimbora-Zovko T; Osmak M
    Int J Cancer; 2004 Jul; 110(5):660-7. PubMed ID: 15146554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of suicide gene delivery in pancreatic cancer cells via FGF receptors.
    Kleeff J; Fukahi K; Lopez ME; Friess H; Büchler MW; Sosnowski BA; Korc M
    Cancer Gene Ther; 2002 Jun; 9(6):522-32. PubMed ID: 12032663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.